高線量放射線治療システムに関する市場調査:リニアック装置の需要は今後も高水準を維持Market Study on High-dose Radiotherapy Systems: Demand for LINAC Devices to Remain High Going Forward 高線量放射線治療システム市場:レポート範囲 Persistence Market Research社の最新レポート「世界の高線量放射線治療システム市場」は、機会や現在の市場展望を評価し、市場に影響を与える対応セクションに関... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー高線量放射線治療システム市場:レポート範囲Persistence Market Research社の最新レポート「世界の高線量放射線治療システム市場」は、機会や現在の市場展望を評価し、市場に影響を与える対応セクションに関する詳細な分析や最新情報を提供しています。この調査レポートは、市場の促進要因、阻害要因、動向、機会を含む現在の市場ダイナミクスに関する詳細な洞察を提供しています。この市場調査の主な目的は、高線量放射線治療システム市場が2023年から2033年の予測期間中にどのように推移するかについての独占情報を提示することです。 市場の成功成長のための重要な指標は、市場の前年比(YoY)成長分析、複合年間成長率(CAGR)などを含むこの包括的なレポートで提示されており、Persistence Market Research社の調査で網羅的に説明されています。この調査レポートは、高線量放射線治療システムの需要と調査期間中の定量的な発展機会を知る読者を支援することができます。 この調査レポートは、投資家、メーカー、サービスプロバイダ、流通業者、サプライヤなどのランドスケープの株主にとって有益であり、高線量放射線治療システム市場で繁栄するための適切な事業戦略を策定するのに役立ちます。高線量放射線治療システム市場の株主、業界の専門家、投資家、研究者、記者、ビジネス愛好家は、このPersistence Market Researchの調査レポートで紹介されている洞察や情報を活用することができます。 高線量放射線治療システム市場のビジネスシナリオに影響を与えるマクロ経済変数だけでなく、マクロ経済変数に関連する情報だけでなく、市場統計も現在の調査に含まれています。市場の潜在的な発展に応じて、実質的な洞察も本レポートに記載されています。さらに、本レポートで提出されたデータにより、業界のマイナー企業や新規参入企業は、市場での牽引力を獲得するために適切な企業選択を行う際に役立ちます。 主要市場セグメント Persistence Market Research社の高線量放射線治療システム市場に関する調査レポートは、製品、エンドユーザー、地域の3つの重要なセグメントに分けた情報を提供しています。本レポートは、これらのカテゴリに関連する重要な市場ダイナミクスと成長パラメータに関する包括的なデータと情報を提供します。 属性の詳細 製品 リニアック装置 陽子線治療装置 ブラキセラピー エンドユーザー 病院 がん治療センター 研究センター 地域 北米 ラテンアメリカ ヨーロッパ 南アジア 東アジア オセアニア 中東・アフリカ(MEA) レポートで回答した主な質問 今後数年間、高線量放射線治療システムの最も収益性の高い市場であり続けるのはどの地域か? トレンドの変化は市場にどのような影響を与えるのか? 市場プレーヤーは先進地域の低空飛行チャンスをどのように捉えるか? 高線量放射線治療システム市場における関係者の戦略は? 投資家が市場に投資する際に注意すべき、また取り組む可能性のある阻害要因は何か? 市場に影響を与える開発動向は何か? 高線量放射線治療システム市場の企業は、先進国および新興国の成長機会をどのように活用できるか? 調査方法 Persistence Market Research社の調査レポートでは、高線量放射線治療システム市場の成長に関する広範な調査を実施し、市場の今後の成長パラメータに関する結論を得るために、独自の調査手法を活用しています。この調査手法は一次調査と二次調査を組み合わせたもので、アナリストが結論の正確性と信頼性を確保するのに役立ちます。 市場調査作成時にアナリストが参照した二次資料には、政府機関の統計、業界誌、白書、社内外の独自データベースなどがあります。アナリストは、一次資料として本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行った。 一次および二次リソースから取得した包括的な情報は、市場の企業からの検証として機能し、高線量放射線治療システム市場の成長見通しに関するPersistence Market Research社の予測をより正確で信頼性の高いものにしています。 目次1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Development/Innovation Trends 4. Value Added Insights 4.1. Adoption Rate/Usage Analysis, by Region 4.2. Installed Base Scenario, By Key Countries 4.3. Disease Epidemiology 4.4. Regulatory Landscape, by Country 4.5. Reimbursement Scenario 4.6. Value Chain Analysis 4.7. PESTEL Analysis 4.8. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Expenditure Outlook 5.1.2. Global Radiotherapy Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rising Cancer Incidence 5.2.2. Advances in Radiotherapy Technology 5.2.3. Rise in Awareness Campaigns About the Benefits of Radiotherapy for Cancer Treatment 5.2.4. Increasing Use of Particle Therapy 5.2.5. Growing Healthcare Expenditure 5.2.6. Increasing Accessibility of Radiotherapy Services 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand Value or Size (US$ Mn) Analysis 2017–2022 and Forecast, 2023–2033 6.1. Historical Market Value (US$ Mn) Analysis, 2017–2022 6.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2017–2022 and Forecast 2023–2033, By Product 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Mn) Analysis By Product, 2017–2022 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2023–2033 7.3.1. LINAC Devices 7.3.2. Proton Therapy Devices 7.3.3. Brachytherapy 7.4. Market Attractiveness Analysis By Product 8. Global Market Analysis 2017–2022 and Forecast 2023–2033, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis, By End User, 2017–2022 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023–2033 8.3.1. Hospitals 8.3.2. Cancer Treatment Centers & Clinics 8.3.3. Research Centers 8.4. Market Attractiveness Analysis By End User 9. Global Market Analysis 2017–2022 and Forecast 2023–2033, By Region 9.1. Introduction 9.2. Historical Market Size (US$ Mn) Trend Analysis by Region, 2017–2022 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2023–2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. South Asia 9.3.5. East Asia 9.3.6. Oceania 9.3.7. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2017–2022 and Forecast 2023–2033 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017–2022 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 10.3.1. By Country 10.3.1.1. U.S. 10.3.1.2. Canada 10.3.2. By Product 10.3.3. By End User 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Product 10.4.3. By End User 10.5. Key Market Participants - Intensity Mapping 10.6. Drivers and Restraints - Impact Analysis 10.7. Country Level Analysis & Forecast 10.7.1. U.S. Market Analysis 10.7.1.1. Introduction 10.7.1.2. Market Analysis and Forecast by Market Taxonomy 10.7.1.2.1. By Product 10.7.1.2.2. By End User 10.7.2. Canada Market Analysis 10.7.2.1. Introduction 10.7.2.2. Market Analysis and Forecast by Market Taxonomy 10.7.2.2.1. By Product 10.7.2.2.2. By End User 11. Latin America Market Analysis 2017–2022 and Forecast 2023–2033 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017–2022 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Argentina 11.3.1.4. Rest of Latin America 11.3.2. By Product 11.3.3. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Product 11.4.3. By End User 11.5. Key Market Participants - Intensity Mapping 11.6. Drivers and Restraints - Impact Analysis 11.7. Country Level Analysis & Forecast 11.7.1. Brazil Market Analysis 11.7.1.1. Introduction 11.7.1.2. Market Analysis and Forecast by Market Taxonomy 11.7.1.2.1. By Product 11.7.1.2.2. By End User 11.7.2. Mexico Market Analysis 11.7.2.1. Introduction 11.7.2.2. Market Analysis and Forecast by Market Taxonomy 11.7.2.2.1. By Product 11.7.2.2.2. By End User 11.7.3. Argentina Market Analysis 11.7.3.1. Introduction 11.7.3.2. Market Analysis and Forecast by Market Taxonomy 11.7.3.2.1. By Product 11.7.3.2.2. By End User 12. Europe Market Analysis 2017–2022 and Forecast 2023–2033 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017–2022 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. Italy 12.3.1.3. France 12.3.1.4. U.K. 12.3.1.5. Spain 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Product 12.3.3. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product 12.4.3. By End User 12.5. Key Market Participants - Intensity Mapping 12.6. Drivers and Restraints - Impact Analysis 12.7. Country Level Analysis & Forecast 12.7.1. Germany Market Analysis 12.7.1.1. Introduction 12.7.1.2. Market Analysis and Forecast by Market Taxonomy 12.7.1.2.1. By Product 12.7.1.2.2. By End User 12.7.2. Italy Market Analysis 12.7.2.1. Introduction 12.7.2.2. Market Analysis and Forecast by Market Taxonomy 12.7.2.2.1. By Product 12.7.2.2.2. By End User 12.7.3. France Market Analysis 12.7.3.1. Introduction 12.7.3.2. Market Analysis and Forecast by Market Taxonomy 12.7.3.2.1. By Product 12.7.3.2.2. By End User 12.7.4. U.K. Market Analysis 12.7.4.1. Introduction 12.7.4.2. Market Analysis and Forecast by Market Taxonomy 12.7.4.2.1. By Product 12.7.4.2.2. By End User 12.7.5. Spain Market Analysis 12.7.5.1. Introduction 12.7.5.2. Market Analysis and Forecast by Market Taxonomy 12.7.5.2.1. By Product 12.7.5.2.2. By End User 12.7.6. BENELUX Market Analysis 12.7.6.1. Introduction 12.7.6.2. Market Analysis and Forecast by Market Taxonomy 12.7.6.2.1. By Product 12.7.6.2.2. By End User 12.7.7. Russia Market Analysis 12.7.7.1. Introduction 12.7.7.2. Market Analysis and Forecast by Market Taxonomy 12.7.7.2.1. By Product 12.7.7.2.2. By End User 13. East Asia Market Analysis 2017–2022 and Forecast 2023–2033 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017–2022 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Product 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By End User 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 13.7. Country Level Analysis & Forecast 13.7.1. China Market Analysis 13.7.1.1. Introduction 13.7.1.2. Market Analysis and Forecast by Market Taxonomy 13.7.1.2.1. By Product 13.7.1.2.2. By End User 13.7.2. Japan Market Analysis 13.7.2.1. Introduction 13.7.2.2. Market Analysis and Forecast by Market Taxonomy 13.7.2.2.1. By Product 13.7.2.2.2. By End User 13.7.3. South Korea Market Analysis 13.7.3.1. Introduction 13.7.3.2. Market Analysis and Forecast by Market Taxonomy 13.7.3.2.1. By Product 13.7.3.2.2. By End User 14. South Asia Market Analysis 2017–2022 and Forecast 2023–2033 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017–2022 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Indonesia 14.3.1.3. Thailand 14.3.1.4. Malaysia 14.3.1.5. Rest of South Asia 14.3.2. By Product 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By End User 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 14.7. Country Level Analysis & Forecast 14.7.1. India Market Analysis 14.7.1.1. Introduction 14.7.1.2. Market Analysis and Forecast by Market Taxonomy 14.7.1.2.1. By Product 14.7.1.2.2. By End User 14.7.2. Malaysia Market Analysis 14.7.2.1. Introduction 14.7.2.2. Market Analysis and Forecast by Market Taxonomy 14.7.2.2.1. By Product 14.7.2.2.2. By End User 14.7.3. Thailand Market Analysis 14.7.3.1. Introduction 14.7.3.2. Market Analysis and Forecast by Market Taxonomy 14.7.3.2.1. By Product 14.7.3.2.2. By End User 14.7.4. Indonesia Market Analysis 14.7.4.1. Introduction 14.7.4.2. Market Analysis and Forecast by Market Taxonomy 14.7.4.2.1. By Product 14.7.4.2.2. By End User 15. Oceania Market 2016-2021 and Forecast 2023–2033 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017–2022 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 15.3.1. By Country 15.3.1.1. Australia 15.3.1.2. New Zealand 15.3.2. By Product 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By End User 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 15.7. Country Level Analysis & Forecast 15.7.1. Australia Market Analysis 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast by Market Taxonomy 15.7.1.2.1. By Product 15.7.1.2.2. By End User 15.7.2. New Zealand Market Analysis 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast by Market Taxonomy 15.7.2.2.1. By Product 15.7.2.2.2. By End User 16. Middle East and Africa (Middle East and Africa) Market Analysis 2017–2022 and Forecast 2023–2033 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017–2022 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 16.3.1. By Country 16.3.1.1. GCC Countries 16.3.1.2. Türkiye 16.3.1.3. South Africa 16.3.1.4. Northern Africa 16.3.1.5. Rest of Middle East and Africa 16.3.2. By Product 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By End User 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 16.7. Country Level Analysis & Forecast 16.7.1. GCC Countries Market Analysis 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Product 16.7.1.2.2. By End User 16.7.2. Türkiye Market Analysis 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Product 16.7.2.2.2. By End User 16.7.3. South Africa Market Analysis 16.7.3.1. Introduction 16.7.3.2. Market Analysis and Forecast by Market Taxonomy 16.7.3.2.1. By Product 16.7.3.2.2. By End User 16.7.4. Northern Africa Market Analysis 16.7.4.1. Introduction 16.7.4.2. Market Analysis and Forecast by Market Taxonomy 16.7.4.2.1. By Product 16.7.4.2.2. By End User 17. Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Share Analysis of Top Players (%) 17.3. Market Presence Analysis 17.3.1. By Regional Footprint of Players 17.3.2. Product Footprint of Players 17.3.3. Channel Footprint of Players 18. Competition Analysis 18.1. Competition Dashboard 18.2. Branding and Promotional Strategies, By Key Players 18.3. Key Development Analysis 18.4. Competition Deep Dive 18.4.1. Varian Medical Systems 18.4.1.1. Overview 18.4.1.2. Product & Services Portfolio 18.4.1.3. Key Financials 18.4.1.4. SWOT Analysis 18.4.1.5. Key Developments 18.4.1.6. Sales Footprint 18.4.1.7. Strategy Overview 18.4.1.7.1. Marketing Strategy 18.4.1.7.2. Product Strategy 18.4.1.7.3. Channel Strategy 18.4.2. Elekta AB 18.4.2.1. Overview 18.4.2.2. Product & Services Portfolio 18.4.2.3. Key Financials 18.4.2.4. SWOT Analysis 18.4.2.5. Key Developments 18.4.2.6. Sales Footprint 18.4.2.7. Strategy Overview 18.4.2.7.1. Marketing Strategy 18.4.2.7.2. Product Strategy 18.4.2.7.3. Channel Strategy 18.4.3. Accuray Incorporated 18.4.3.1. Overview 18.4.3.2. Product & Services Portfolio 18.4.3.3. Key Financials 18.4.3.4. SWOT Analysis 18.4.3.5. Key Developments 18.4.3.6. Sales Footprint 18.4.3.7. Strategy Overview 18.4.3.7.1. Marketing Strategy 18.4.3.7.2. Product Strategy 18.4.3.7.3. Channel Strategy 18.4.4. Mevion Medical Systems 18.4.4.1. Overview 18.4.4.2. Product & Services Portfolio 18.4.4.3. Key Financials 18.4.4.4. SWOT Analysis 18.4.4.5. Key Developments 18.4.4.6. Sales Footprint 18.4.4.7. Strategy Overview 18.4.4.7.1. Marketing Strategy 18.4.4.7.2. Product Strategy 18.4.4.7.3. Channel Strategy 18.4.5. ViewRay, Inc. 18.4.5.1. Overview 18.4.5.2. Product & Services Portfolio 18.4.5.3. Key Financials 18.4.5.4. SWOT Analysis 18.4.5.5. Key Developments 18.4.5.6. Sales Footprint 18.4.5.7. Strategy Overview 18.4.5.7.1. Marketing Strategy 18.4.5.7.2. Product Strategy 18.4.5.7.3. Channel Strategy 18.4.6. Isoray, Inc. 18.4.6.1. Overview 18.4.6.2. Product & Services Portfolio 18.4.6.3. Key Financials 18.4.6.4. SWOT Analysis 18.4.6.5. Key Developments 18.4.6.6. Sales Footprint 18.4.6.7. Strategy Overview 18.4.6.7.1. Marketing Strategy 18.4.6.7.2. Product Strategy 18.4.6.7.3. Channel Strategy 18.4.7. Hitachi Ltd. 18.4.7.1. Overview 18.4.7.2. Product & Services Portfolio 18.4.7.3. Key Financials 18.4.7.4. SWOT Analysis 18.4.7.5. Key Developments 18.4.7.6. Sales Footprint 18.4.7.7. Strategy Overview 18.4.7.7.1. Marketing Strategy 18.4.7.7.2. Product Strategy 18.4.7.7.3. Channel Strategy 18.4.8. C.R. Bard 18.4.8.1. Overview 18.4.8.2. Product & Services Portfolio 18.4.8.3. Key Financials 18.4.8.4. SWOT Analysis 18.4.8.5. Key Developments 18.4.8.6. Sales Footprint 18.4.8.7. Strategy Overview 18.4.8.7.1. Marketing Strategy 18.4.8.7.2. Product Strategy 18.4.8.7.3. Channel Strategy 18.4.9. Panacea Medical Technologies 18.4.9.1. Overview 18.4.9.2. Product & Services Portfolio 18.4.9.3. Key Financials 18.4.9.4. SWOT Analysis 18.4.9.5. Key Developments 18.4.9.6. Sales Footprint 18.4.9.7. Strategy Overview 18.4.9.7.1. Marketing Strategy 18.4.9.7.2. Product Strategy 18.4.9.7.3. Channel Strategy 18.4.10. Johari Digital Healthcare Ltd. 18.4.10.1. Overview 18.4.10.2. Product & Services Portfolio 18.4.10.3. Key Financials 18.4.10.4. SWOT Analysis 18.4.10.5. Key Developments 18.4.10.6. Sales Footprint 18.4.10.7. Strategy Overview 18.4.10.7.1. Marketing Strategy 18.4.10.7.2. Product Strategy 18.4.10.7.3. Channel Strategy 18.4.11. Diapulse Corporation of America 18.4.11.1. Overview 18.4.11.2. Product & Services Portfolio 18.4.11.3. Key Financials 18.4.11.4. SWOT Analysis 18.4.11.5. Key Developments 18.4.11.6. Sales Footprint 18.4.11.7. Strategy Overview 18.4.11.7.1. Marketing Strategy 18.4.11.7.2. Product Strategy 18.4.11.7.3. Channel Strategy 18.4.12. Neutron Products, Inc. 18.4.12.1. Overview 18.4.12.2. Product & Services Portfolio 18.4.12.3. Key Financials 18.4.12.4. SWOT Analysis 18.4.12.5. Key Developments 18.4.12.6. Sales Footprint 18.4.12.7. Strategy Overview 18.4.12.7.1. Marketing Strategy 18.4.12.7.2. Product Strategy 18.4.12.7.3. Channel Strategy 18.4.13. Agile MV 18.4.13.1. Overview 18.4.13.2. Product & Services Portfolio 18.4.13.3. Key Financials 18.4.13.4. SWOT Analysis 18.4.13.5. Key Developments 18.4.13.6. Sales Footprint 18.4.13.7. Strategy Overview 18.4.13.7.1. Marketing Strategy 18.4.13.7.2. Product Strategy 18.4.13.7.3. Channel Strategy 18.4.14. TomoTherapy Incorporated 18.4.14.1. Overview 18.4.14.2. Product & Services Portfolio 18.4.14.3. Key Financials 18.4.14.4. SWOT Analysis 18.4.14.5. Key Developments 18.4.14.6. Sales Footprint 18.4.14.7. Strategy Overview 18.4.14.7.1. Marketing Strategy 18.4.14.7.2. Product Strategy 18.4.14.7.3. Channel Strategy 18.4.15. P-Cure, Ltd. 18.4.15.1. Overview 18.4.15.2. Product & Services Portfolio 18.4.15.3. Key Financials 18.4.15.4. SWOT Analysis 18.4.15.5. Key Developments 18.4.15.6. Sales Footprint 18.4.15.7. Strategy Overview 18.4.15.7.1. Marketing Strategy 18.4.15.7.2. Product Strategy 18.4.15.7.3. Channel Strategy 18.4.16. Provison Healthcare, LLC 18.4.16.1. Overview 18.4.16.2. Product & Services Portfolio 18.4.16.3. Key Financials 18.4.16.4. SWOT Analysis 18.4.16.5. Key Developments 18.4.16.6. Sales Footprint 18.4.16.7. Strategy Overview 18.4.16.7.1. Marketing Strategy 18.4.16.7.2. Product Strategy 18.4.16.7.3. Channel Strategy 18.4.17. Ion Beam Applications S.A. 18.4.17.1. Overview 18.4.17.2. Product & Services Portfolio 18.4.17.3. Key Financials 18.4.17.4. SWOT Analysis 18.4.17.5. Key Developments 18.4.17.6. Sales Footprint 18.4.17.7. Strategy Overview 18.4.17.7.1. Marketing Strategy 18.4.17.7.2. Product Strategy 18.4.17.7.3. Channel Strategy 19. Assumptions and Acronyms Used 20. Research Methodology
SummaryHigh-dose Radiotherapy Systems Market: Report Scope Table of Contents1. Executive Summary1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply-Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions and Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Development/Innovation Trends 4. Value Added Insights 4.1. Adoption Rate/Usage Analysis, by Region 4.2. Installed Base Scenario, By Key Countries 4.3. Disease Epidemiology 4.4. Regulatory Landscape, by Country 4.5. Reimbursement Scenario 4.6. Value Chain Analysis 4.7. PESTEL Analysis 4.8. Porter’s Analysis 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global Healthcare Expenditure Outlook 5.1.2. Global Radiotherapy Market Outlook 5.2. Forecast Factors - Relevance & Impact 5.2.1. Rising Cancer Incidence 5.2.2. Advances in Radiotherapy Technology 5.2.3. Rise in Awareness Campaigns About the Benefits of Radiotherapy for Cancer Treatment 5.2.4. Increasing Use of Particle Therapy 5.2.5. Growing Healthcare Expenditure 5.2.6. Increasing Accessibility of Radiotherapy Services 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. Global Market Demand Value or Size (US$ Mn) Analysis 2017–2022 and Forecast, 2023–2033 6.1. Historical Market Value (US$ Mn) Analysis, 2017–2022 6.2. Current and Future Market Value (US$ Mn) Projections, 2023–2033 6.2.1. Y-o-Y Growth Trend Analysis 6.2.2. Absolute $ Opportunity Analysis 7. Global Market Analysis 2017–2022 and Forecast 2023–2033, By Product 7.1. Introduction / Key Findings 7.2. Historical Market Size (US$ Mn) Analysis By Product, 2017–2022 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2023–2033 7.3.1. LINAC Devices 7.3.2. Proton Therapy Devices 7.3.3. Brachytherapy 7.4. Market Attractiveness Analysis By Product 8. Global Market Analysis 2017–2022 and Forecast 2023–2033, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Mn) Analysis, By End User, 2017–2022 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2023–2033 8.3.1. Hospitals 8.3.2. Cancer Treatment Centers & Clinics 8.3.3. Research Centers 8.4. Market Attractiveness Analysis By End User 9. Global Market Analysis 2017–2022 and Forecast 2023–2033, By Region 9.1. Introduction 9.2. Historical Market Size (US$ Mn) Trend Analysis by Region, 2017–2022 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2023–2033 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. South Asia 9.3.5. East Asia 9.3.6. Oceania 9.3.7. Middle East and Africa (MEA) 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2017–2022 and Forecast 2023–2033 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017–2022 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 10.3.1. By Country 10.3.1.1. U.S. 10.3.1.2. Canada 10.3.2. By Product 10.3.3. By End User 10.4. Market Attractiveness Analysis 10.4.1. By Country 10.4.2. By Product 10.4.3. By End User 10.5. Key Market Participants - Intensity Mapping 10.6. Drivers and Restraints - Impact Analysis 10.7. Country Level Analysis & Forecast 10.7.1. U.S. Market Analysis 10.7.1.1. Introduction 10.7.1.2. Market Analysis and Forecast by Market Taxonomy 10.7.1.2.1. By Product 10.7.1.2.2. By End User 10.7.2. Canada Market Analysis 10.7.2.1. Introduction 10.7.2.2. Market Analysis and Forecast by Market Taxonomy 10.7.2.2.1. By Product 10.7.2.2.2. By End User 11. Latin America Market Analysis 2017–2022 and Forecast 2023–2033 11.1. Introduction 11.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017–2022 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 11.3.1. By Country 11.3.1.1. Brazil 11.3.1.2. Mexico 11.3.1.3. Argentina 11.3.1.4. Rest of Latin America 11.3.2. By Product 11.3.3. By End User 11.4. Market Attractiveness Analysis 11.4.1. By Country 11.4.2. By Product 11.4.3. By End User 11.5. Key Market Participants - Intensity Mapping 11.6. Drivers and Restraints - Impact Analysis 11.7. Country Level Analysis & Forecast 11.7.1. Brazil Market Analysis 11.7.1.1. Introduction 11.7.1.2. Market Analysis and Forecast by Market Taxonomy 11.7.1.2.1. By Product 11.7.1.2.2. By End User 11.7.2. Mexico Market Analysis 11.7.2.1. Introduction 11.7.2.2. Market Analysis and Forecast by Market Taxonomy 11.7.2.2.1. By Product 11.7.2.2.2. By End User 11.7.3. Argentina Market Analysis 11.7.3.1. Introduction 11.7.3.2. Market Analysis and Forecast by Market Taxonomy 11.7.3.2.1. By Product 11.7.3.2.2. By End User 12. Europe Market Analysis 2017–2022 and Forecast 2023–2033 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017–2022 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 12.3.1. By Country 12.3.1.1. Germany 12.3.1.2. Italy 12.3.1.3. France 12.3.1.4. U.K. 12.3.1.5. Spain 12.3.1.6. BENELUX 12.3.1.7. Russia 12.3.1.8. Rest of Europe 12.3.2. By Product 12.3.3. By End User 12.4. Market Attractiveness Analysis 12.4.1. By Country 12.4.2. By Product 12.4.3. By End User 12.5. Key Market Participants - Intensity Mapping 12.6. Drivers and Restraints - Impact Analysis 12.7. Country Level Analysis & Forecast 12.7.1. Germany Market Analysis 12.7.1.1. Introduction 12.7.1.2. Market Analysis and Forecast by Market Taxonomy 12.7.1.2.1. By Product 12.7.1.2.2. By End User 12.7.2. Italy Market Analysis 12.7.2.1. Introduction 12.7.2.2. Market Analysis and Forecast by Market Taxonomy 12.7.2.2.1. By Product 12.7.2.2.2. By End User 12.7.3. France Market Analysis 12.7.3.1. Introduction 12.7.3.2. Market Analysis and Forecast by Market Taxonomy 12.7.3.2.1. By Product 12.7.3.2.2. By End User 12.7.4. U.K. Market Analysis 12.7.4.1. Introduction 12.7.4.2. Market Analysis and Forecast by Market Taxonomy 12.7.4.2.1. By Product 12.7.4.2.2. By End User 12.7.5. Spain Market Analysis 12.7.5.1. Introduction 12.7.5.2. Market Analysis and Forecast by Market Taxonomy 12.7.5.2.1. By Product 12.7.5.2.2. By End User 12.7.6. BENELUX Market Analysis 12.7.6.1. Introduction 12.7.6.2. Market Analysis and Forecast by Market Taxonomy 12.7.6.2.1. By Product 12.7.6.2.2. By End User 12.7.7. Russia Market Analysis 12.7.7.1. Introduction 12.7.7.2. Market Analysis and Forecast by Market Taxonomy 12.7.7.2.1. By Product 12.7.7.2.2. By End User 13. East Asia Market Analysis 2017–2022 and Forecast 2023–2033 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017–2022 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 13.3.1. By Country 13.3.1.1. China 13.3.1.2. Japan 13.3.1.3. South Korea 13.3.2. By Product 13.3.3. By End User 13.4. Market Attractiveness Analysis 13.4.1. By Country 13.4.2. By Product 13.4.3. By End User 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 13.7. Country Level Analysis & Forecast 13.7.1. China Market Analysis 13.7.1.1. Introduction 13.7.1.2. Market Analysis and Forecast by Market Taxonomy 13.7.1.2.1. By Product 13.7.1.2.2. By End User 13.7.2. Japan Market Analysis 13.7.2.1. Introduction 13.7.2.2. Market Analysis and Forecast by Market Taxonomy 13.7.2.2.1. By Product 13.7.2.2.2. By End User 13.7.3. South Korea Market Analysis 13.7.3.1. Introduction 13.7.3.2. Market Analysis and Forecast by Market Taxonomy 13.7.3.2.1. By Product 13.7.3.2.2. By End User 14. South Asia Market Analysis 2017–2022 and Forecast 2023–2033 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017–2022 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 14.3.1. By Country 14.3.1.1. India 14.3.1.2. Indonesia 14.3.1.3. Thailand 14.3.1.4. Malaysia 14.3.1.5. Rest of South Asia 14.3.2. By Product 14.3.3. By End User 14.4. Market Attractiveness Analysis 14.4.1. By Country 14.4.2. By Product 14.4.3. By End User 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 14.7. Country Level Analysis & Forecast 14.7.1. India Market Analysis 14.7.1.1. Introduction 14.7.1.2. Market Analysis and Forecast by Market Taxonomy 14.7.1.2.1. By Product 14.7.1.2.2. By End User 14.7.2. Malaysia Market Analysis 14.7.2.1. Introduction 14.7.2.2. Market Analysis and Forecast by Market Taxonomy 14.7.2.2.1. By Product 14.7.2.2.2. By End User 14.7.3. Thailand Market Analysis 14.7.3.1. Introduction 14.7.3.2. Market Analysis and Forecast by Market Taxonomy 14.7.3.2.1. By Product 14.7.3.2.2. By End User 14.7.4. Indonesia Market Analysis 14.7.4.1. Introduction 14.7.4.2. Market Analysis and Forecast by Market Taxonomy 14.7.4.2.1. By Product 14.7.4.2.2. By End User 15. Oceania Market 2016-2021 and Forecast 2023–2033 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Analysis by Market Taxonomy, 2017–2022 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 15.3.1. By Country 15.3.1.1. Australia 15.3.1.2. New Zealand 15.3.2. By Product 15.3.3. By End User 15.4. Market Attractiveness Analysis 15.4.1. By Country 15.4.2. By Product 15.4.3. By End User 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 15.7. Country Level Analysis & Forecast 15.7.1. Australia Market Analysis 15.7.1.1. Introduction 15.7.1.2. Market Analysis and Forecast by Market Taxonomy 15.7.1.2.1. By Product 15.7.1.2.2. By End User 15.7.2. New Zealand Market Analysis 15.7.2.1. Introduction 15.7.2.2. Market Analysis and Forecast by Market Taxonomy 15.7.2.2.1. By Product 15.7.2.2.2. By End User 16. Middle East and Africa (Middle East and Africa) Market Analysis 2017–2022 and Forecast 2023–2033 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2017–2022 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2023–2033 16.3.1. By Country 16.3.1.1. GCC Countries 16.3.1.2. Türkiye 16.3.1.3. South Africa 16.3.1.4. Northern Africa 16.3.1.5. Rest of Middle East and Africa 16.3.2. By Product 16.3.3. By End User 16.4. Market Attractiveness Analysis 16.4.1. By Country 16.4.2. By Product 16.4.3. By End User 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 16.7. Country Level Analysis & Forecast 16.7.1. GCC Countries Market Analysis 16.7.1.1. Introduction 16.7.1.2. Market Analysis and Forecast by Market Taxonomy 16.7.1.2.1. By Product 16.7.1.2.2. By End User 16.7.2. Türkiye Market Analysis 16.7.2.1. Introduction 16.7.2.2. Market Analysis and Forecast by Market Taxonomy 16.7.2.2.1. By Product 16.7.2.2.2. By End User 16.7.3. South Africa Market Analysis 16.7.3.1. Introduction 16.7.3.2. Market Analysis and Forecast by Market Taxonomy 16.7.3.2.1. By Product 16.7.3.2.2. By End User 16.7.4. Northern Africa Market Analysis 16.7.4.1. Introduction 16.7.4.2. Market Analysis and Forecast by Market Taxonomy 16.7.4.2.1. By Product 16.7.4.2.2. By End User 17. Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Share Analysis of Top Players (%) 17.3. Market Presence Analysis 17.3.1. By Regional Footprint of Players 17.3.2. Product Footprint of Players 17.3.3. Channel Footprint of Players 18. Competition Analysis 18.1. Competition Dashboard 18.2. Branding and Promotional Strategies, By Key Players 18.3. Key Development Analysis 18.4. Competition Deep Dive 18.4.1. Varian Medical Systems 18.4.1.1. Overview 18.4.1.2. Product & Services Portfolio 18.4.1.3. Key Financials 18.4.1.4. SWOT Analysis 18.4.1.5. Key Developments 18.4.1.6. Sales Footprint 18.4.1.7. Strategy Overview 18.4.1.7.1. Marketing Strategy 18.4.1.7.2. Product Strategy 18.4.1.7.3. Channel Strategy 18.4.2. Elekta AB 18.4.2.1. Overview 18.4.2.2. Product & Services Portfolio 18.4.2.3. Key Financials 18.4.2.4. SWOT Analysis 18.4.2.5. Key Developments 18.4.2.6. Sales Footprint 18.4.2.7. Strategy Overview 18.4.2.7.1. Marketing Strategy 18.4.2.7.2. Product Strategy 18.4.2.7.3. Channel Strategy 18.4.3. Accuray Incorporated 18.4.3.1. Overview 18.4.3.2. Product & Services Portfolio 18.4.3.3. Key Financials 18.4.3.4. SWOT Analysis 18.4.3.5. Key Developments 18.4.3.6. Sales Footprint 18.4.3.7. Strategy Overview 18.4.3.7.1. Marketing Strategy 18.4.3.7.2. Product Strategy 18.4.3.7.3. Channel Strategy 18.4.4. Mevion Medical Systems 18.4.4.1. Overview 18.4.4.2. Product & Services Portfolio 18.4.4.3. Key Financials 18.4.4.4. SWOT Analysis 18.4.4.5. Key Developments 18.4.4.6. Sales Footprint 18.4.4.7. Strategy Overview 18.4.4.7.1. Marketing Strategy 18.4.4.7.2. Product Strategy 18.4.4.7.3. Channel Strategy 18.4.5. ViewRay, Inc. 18.4.5.1. Overview 18.4.5.2. Product & Services Portfolio 18.4.5.3. Key Financials 18.4.5.4. SWOT Analysis 18.4.5.5. Key Developments 18.4.5.6. Sales Footprint 18.4.5.7. Strategy Overview 18.4.5.7.1. Marketing Strategy 18.4.5.7.2. Product Strategy 18.4.5.7.3. Channel Strategy 18.4.6. Isoray, Inc. 18.4.6.1. Overview 18.4.6.2. Product & Services Portfolio 18.4.6.3. Key Financials 18.4.6.4. SWOT Analysis 18.4.6.5. Key Developments 18.4.6.6. Sales Footprint 18.4.6.7. Strategy Overview 18.4.6.7.1. Marketing Strategy 18.4.6.7.2. Product Strategy 18.4.6.7.3. Channel Strategy 18.4.7. Hitachi Ltd. 18.4.7.1. Overview 18.4.7.2. Product & Services Portfolio 18.4.7.3. Key Financials 18.4.7.4. SWOT Analysis 18.4.7.5. Key Developments 18.4.7.6. Sales Footprint 18.4.7.7. Strategy Overview 18.4.7.7.1. Marketing Strategy 18.4.7.7.2. Product Strategy 18.4.7.7.3. Channel Strategy 18.4.8. C.R. Bard 18.4.8.1. Overview 18.4.8.2. Product & Services Portfolio 18.4.8.3. Key Financials 18.4.8.4. SWOT Analysis 18.4.8.5. Key Developments 18.4.8.6. Sales Footprint 18.4.8.7. Strategy Overview 18.4.8.7.1. Marketing Strategy 18.4.8.7.2. Product Strategy 18.4.8.7.3. Channel Strategy 18.4.9. Panacea Medical Technologies 18.4.9.1. Overview 18.4.9.2. Product & Services Portfolio 18.4.9.3. Key Financials 18.4.9.4. SWOT Analysis 18.4.9.5. Key Developments 18.4.9.6. Sales Footprint 18.4.9.7. Strategy Overview 18.4.9.7.1. Marketing Strategy 18.4.9.7.2. Product Strategy 18.4.9.7.3. Channel Strategy 18.4.10. Johari Digital Healthcare Ltd. 18.4.10.1. Overview 18.4.10.2. Product & Services Portfolio 18.4.10.3. Key Financials 18.4.10.4. SWOT Analysis 18.4.10.5. Key Developments 18.4.10.6. Sales Footprint 18.4.10.7. Strategy Overview 18.4.10.7.1. Marketing Strategy 18.4.10.7.2. Product Strategy 18.4.10.7.3. Channel Strategy 18.4.11. Diapulse Corporation of America 18.4.11.1. Overview 18.4.11.2. Product & Services Portfolio 18.4.11.3. Key Financials 18.4.11.4. SWOT Analysis 18.4.11.5. Key Developments 18.4.11.6. Sales Footprint 18.4.11.7. Strategy Overview 18.4.11.7.1. Marketing Strategy 18.4.11.7.2. Product Strategy 18.4.11.7.3. Channel Strategy 18.4.12. Neutron Products, Inc. 18.4.12.1. Overview 18.4.12.2. Product & Services Portfolio 18.4.12.3. Key Financials 18.4.12.4. SWOT Analysis 18.4.12.5. Key Developments 18.4.12.6. Sales Footprint 18.4.12.7. Strategy Overview 18.4.12.7.1. Marketing Strategy 18.4.12.7.2. Product Strategy 18.4.12.7.3. Channel Strategy 18.4.13. Agile MV 18.4.13.1. Overview 18.4.13.2. Product & Services Portfolio 18.4.13.3. Key Financials 18.4.13.4. SWOT Analysis 18.4.13.5. Key Developments 18.4.13.6. Sales Footprint 18.4.13.7. Strategy Overview 18.4.13.7.1. Marketing Strategy 18.4.13.7.2. Product Strategy 18.4.13.7.3. Channel Strategy 18.4.14. TomoTherapy Incorporated 18.4.14.1. Overview 18.4.14.2. Product & Services Portfolio 18.4.14.3. Key Financials 18.4.14.4. SWOT Analysis 18.4.14.5. Key Developments 18.4.14.6. Sales Footprint 18.4.14.7. Strategy Overview 18.4.14.7.1. Marketing Strategy 18.4.14.7.2. Product Strategy 18.4.14.7.3. Channel Strategy 18.4.15. P-Cure, Ltd. 18.4.15.1. Overview 18.4.15.2. Product & Services Portfolio 18.4.15.3. Key Financials 18.4.15.4. SWOT Analysis 18.4.15.5. Key Developments 18.4.15.6. Sales Footprint 18.4.15.7. Strategy Overview 18.4.15.7.1. Marketing Strategy 18.4.15.7.2. Product Strategy 18.4.15.7.3. Channel Strategy 18.4.16. Provison Healthcare, LLC 18.4.16.1. Overview 18.4.16.2. Product & Services Portfolio 18.4.16.3. Key Financials 18.4.16.4. SWOT Analysis 18.4.16.5. Key Developments 18.4.16.6. Sales Footprint 18.4.16.7. Strategy Overview 18.4.16.7.1. Marketing Strategy 18.4.16.7.2. Product Strategy 18.4.16.7.3. Channel Strategy 18.4.17. Ion Beam Applications S.A. 18.4.17.1. Overview 18.4.17.2. Product & Services Portfolio 18.4.17.3. Key Financials 18.4.17.4. SWOT Analysis 18.4.17.5. Key Developments 18.4.17.6. Sales Footprint 18.4.17.7. Strategy Overview 18.4.17.7.1. Marketing Strategy 18.4.17.7.2. Product Strategy 18.4.17.7.3. Channel Strategy 19. Assumptions and Acronyms Used 20. Research Methodology
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Persistence Market Research社の医療・製薬・メディカルデバイス分野での最新刊レポート
本レポートと同じKEY WORD(demand)の最新刊レポート
よくあるご質問Persistence Market Research社はどのような調査会社ですか?パーシスタンスマーケットリサーチ(Persistence Market Research/PMR)は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|